Mutation and clinical significance of c-fms oncogene in hepatocellular carcinoma

World Chinese Journal of Digestology

Volumn 9, Issue 4, 2001, Pages 392-395

  Cui, J ^a   Dong Hua Yang, ^a   Han Rong Qin, ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Genes, fms; Liver neoplasms genetics; Liver neoplasms pathology; Mutation

Indexed keywords

LEUCINE; PRIMER DNA; SERINE; SINGLE STRANDED DNA;

ARTICLE; CANCER CLASSIFICATION; CANCER TISSUE; CARCINOGENESIS; CELL ONCOGENE; CODON; DNA SEQUENCE; GENE MUTATION; HISTOPATHOLOGY; LIVER CELL CARCINOMA; SEQUENCE ANALYSIS;

EID: 0035055798     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Expression of cancer gene products of IGF-II, IGF-II receptors, CSF-1 receptors in primary hepatic cancer and non-cancerous liver tissue
2. CSF-1 receptor/c-fms and liver cancer
3. Overexpression and mutations of tumor suppressor gene p53 in hepatocellular carcinoma
4. CSF-1 receptor/c-fms and liver cancer
5. Mutation of p53 tumor suppressor gene in hepatocellular carcinoma
6. N-ras gene mutation and hepatitis B virus infection in hepatocellular carcinomas in Guangxi, China
7. mdm2 gene expression in hepatocellular carcinoma and its relationship to p53 gene mutation
8. Expression of IGF-I, IGF-I receptor mRNA in hepatocellular carcinomas and adjacent nontumor tissues
9. The significance of IGF-II gene expressions and mutations in hepatocellular carcinomas and adjacent non-tumor tissues
10. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: Implications of IGF-I receptor gene activation by hepatitis B virus X gene product
11. Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia
12. Identification and characterization of genes associated with human hepatocellular carcinogenesis
13. Significance of nm23 mRNA expression in human hepatocellular carcinoma
14. Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1
15. Expression of HNF-1 alpha and HNF-1 beta in various histological differentiations of hepatocellular carcinoma
16. In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma
17. The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma
18. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver
19. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma
20. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: Report of 46 cases
21. High frequency of p16INK4A gene alterations in hepatocellular carcinoma
22. The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas
23. Mutational study of p16CDKN2/MTS1/INK4A and p57KIP2 genes in hepatocellular carcinoma
24. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population
25. Modified PCR/SSCP and PCR direct seqencing in detection of gene mutation
26. Multiplex PCR-SSCP: A highly effective and efficient method of mutation detection and analysis
27. Microsatellite instability and p53 mutations in hepatocellular carcinoma
28. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma
29. Detection of hepatitis B surface antigen mutants and their integration in human hepatocellular carcinoma
30. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection
31. Gene mutation of transforming growth factor betal type II receptor in hepatocellular carcinoma
32. Genetic alterations in hepatocellular carcinomas: Association between loss of chromosome 4q and p53 gene mutations
33. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiangsu province of China
34. p53 mutations in british patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis
35. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells
36. Polymorphism of p16INK4a gene and rare mutation of p15INK4b gene exon2 in primary hepatocarcinoma
37. Codon 249 mutations of p53 gene in non-neoplastic liver tissues
38. Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma
39. Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas
40. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection
41. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
42. Microsatellite instability in European hepatocellular carcinoma
43. Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients
44. PTEN/MMAC1 mutations in hepatocellular carcinomas
45. Smad2 and Smad4 gene mutations in hepatocellular carcinoma
46. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
47. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis
48. The role of CSF-1 in normal and neoplastic breast physiology
49. CSF-1 signal transduction
50. Signal transduction by the macrophage-colony-stimulating factor receptor (CSF-1R)
51. Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain
52. The effect of activating mutations on dimerization, tyrosine phosphorylation and internalization of the macrophage colony stimulating factor receptor